Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C142 - Neuro-oncology: Navigating Current Trends

Tuesday 04/25/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Wendy Sherman, MD
Neuro-oncology
Participants will have increased knowledge regarding key clinical trial evidence supporting advancements in the treatment of primary and secondary central nervous system tumors, and integrate emerging evidence into treatment paradigms for patients with primary and secondary central nervous system tumors.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM EST Speaker Updates on Primary CNS Tumors
Michael Wren Ruff, MD
04:00 PM - 04:30 PM EST Speaker Contemporary Approach to Metastatic Disease in the CNS
Tobias Walbert, MD, PhD
04:30 PM - 05:00 PM EST Speaker Case Studies
Wendy Sherman, MD
05:00 PM - 05:30 PM EST Discussion Questions and Answers
Wendy Sherman, MD, Michael Wren Ruff, MD, Tobias Walbert, MD, PhD
Faculty Disclosures
Wendy Sherman, MD Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Michael Wren Ruff, MD Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Tobias Walbert, MD, PhD Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.